These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


297 related items for PubMed ID: 23124953

  • 21. Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.
    Fengler K, Ewen S, Höllriegel R, Rommel KP, Kulenthiran S, Lauder L, Cremers B, Schuler G, Linke A, Böhm M, Mahfoud F, Lurz P.
    J Am Heart Assoc; 2017 Aug 10; 6(8):. PubMed ID: 28862930
    [Abstract] [Full Text] [Related]

  • 22. Renal sympathetic nerve ablation for the management of resistant hypertension: an update.
    Thorp AA, Larsen RN, Schlaich MP.
    Curr Opin Nephrol Hypertens; 2013 Nov 10; 22(6):607-14. PubMed ID: 24100214
    [Abstract] [Full Text] [Related]

  • 23. The role of renal denervation for the treatment of resistant hypertension.
    McLellan AJ, Kistler PM, Walton AS, Schlaich MP.
    J Hum Hypertens; 2014 Apr 10; 28(4):218-23. PubMed ID: 24088716
    [Abstract] [Full Text] [Related]

  • 24. Transradial renal denervation for the treatment of resistant hypertension.
    Dong H, Jiang X, Liang T, Zou Y, Guan T, Peng M, Song L, Zhang H, Wu H, Xu B, Yang Y, Gao R.
    J Invasive Cardiol; 2014 Jul 10; 26(7):322-7. PubMed ID: 24993989
    [Abstract] [Full Text] [Related]

  • 25. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.
    Khan NA, Herman RJ, Quinn RR, Rabkin SW, Ravani P, Tobe SW, Feldman RD, Wijeysundera HC, Padwal RS, Canadian Hypertension Education Program.
    Can J Cardiol; 2014 Jan 10; 30(1):16-21. PubMed ID: 24269056
    [Abstract] [Full Text] [Related]

  • 26. Renal denervation to treat resistant hypertension: Guarded optimism.
    Thomas G, Shishehbor MH, Bravo EL, Nally JV.
    Cleve Clin J Med; 2012 Jul 10; 79(7):501-10. PubMed ID: 22751635
    [Abstract] [Full Text] [Related]

  • 27. Safety and performance of the second generation EnligHTN™ Renal Denervation System in patients with drug-resistant, uncontrolled hypertension.
    Worthley SG, Wilkins GT, Webster MW, Montarello JK, Delacroix S, Whitbourn RJ, Warren RJ.
    Atherosclerosis; 2017 Jul 10; 262():94-100. PubMed ID: 28531827
    [Abstract] [Full Text] [Related]

  • 28. Catheter-based renal denervation: Back on track?
    Lauder L, Ewen S, Böhm M, Mahfoud F.
    Eur Heart J; 2018 Dec 07; 39(46):4058-4059. PubMed ID: 30535015
    [No Abstract] [Full Text] [Related]

  • 29. Renal intervention to treat hypertension.
    Patel RA, White CJ.
    Curr Cardiol Rep; 2012 Apr 07; 14(2):142-9. PubMed ID: 22205178
    [Abstract] [Full Text] [Related]

  • 30. Renal sympathetic denervation for resistant hypertension treatment : current perspectives.
    Brandão AA, Campana EM, Magalhães ME, Ferreira E.
    Arq Bras Cardiol; 2013 Oct 07; 101(4):364-71. PubMed ID: 24029963
    [Abstract] [Full Text] [Related]

  • 31. [Catheter-based renal denervation: a new method for resistant hypertension. Initial experiences of the procedure shows significant decrease in blood pressure].
    Rundqvist B, Völz S, Manhem K, Herlitz H, Haraldsson I, Andersson B.
    Lakartidningen; 2013 Oct 07; 110(3):86-8. PubMed ID: 23424985
    [No Abstract] [Full Text] [Related]

  • 32. Catheter-based renal denervation: the next chapter begins.
    Mahfoud F, Schlaich M, Böhm M, Esler M, Lüscher TF.
    Eur Heart J; 2018 Dec 14; 39(47):4144-4149. PubMed ID: 30239686
    [No Abstract] [Full Text] [Related]

  • 33. Renal denervation for resistant hypertension and beyond.
    Laffin LJ, Bakris GL.
    Adv Chronic Kidney Dis; 2015 Mar 14; 22(2):133-9. PubMed ID: 25704350
    [Abstract] [Full Text] [Related]

  • 34. 3D-sympathetic renal denervation increases procedural efficacy in non-responders after percutaneous renal denervation: dream or reality with second generation of devices.
    Versaci F, Nardi S, Trivisonno A, Olivieri C, Caranci F, Prati F.
    Int J Cardiol; 2014 Aug 01; 175(2):370-1. PubMed ID: 24820742
    [No Abstract] [Full Text] [Related]

  • 35. The future of interventional management of hypertension: threats and opportunities.
    Briasoulis A, Bakris G.
    Curr Vasc Pharmacol; 2014 Jan 01; 12(1):69-76. PubMed ID: 23905592
    [Abstract] [Full Text] [Related]

  • 36. The biophysics of renal sympathetic denervation using radiofrequency energy.
    Patel HC, Dhillon PS, Mahfoud F, Lindsay AC, Hayward C, Ernst S, Lyon AR, Rosen SD, di Mario C.
    Clin Res Cardiol; 2014 May 01; 103(5):337-44. PubMed ID: 24077678
    [Abstract] [Full Text] [Related]

  • 37. Catheter-based radiofrequency renal-nerve ablation in patients with resistant hypertension.
    Azizi M, Steichen O, Frank M, Bobrie G, Plouin PF, Sapoval M.
    Eur J Vasc Endovasc Surg; 2012 Mar 01; 43(3):293-9. PubMed ID: 22237510
    [Abstract] [Full Text] [Related]

  • 38. [Renal sympathetic denervation. A novel interventional treatment option for therapy-resistant arterial hypertension].
    Brandt MC, Mahfoud F, Böhm M, Hoppe UC.
    Herz; 2011 Feb 01; 36(1):8-11. PubMed ID: 21222093
    [Abstract] [Full Text] [Related]

  • 39. Renal sympathetic denervation in hypertension.
    Doumas M, Faselis C, Papademetriou V.
    Curr Opin Nephrol Hypertens; 2011 Nov 01; 20(6):647-53. PubMed ID: 21885968
    [Abstract] [Full Text] [Related]

  • 40. Renal denervation for hypertension.
    Bertog SC, Sobotka PA, Sievert H.
    JACC Cardiovasc Interv; 2012 Mar 01; 5(3):249-58. PubMed ID: 22440489
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.